NIAID Site Search

This Word document provides a tool for assessing Organization System Reviews and is translated into Spanish.

Last Reviewed: May 25, 2019

This document provides information about the Biodefense Research Agenda for CDC Category A Agents in February 2002.

Last Reviewed: August 6, 2019

This document provides a progress report about the Biodefense Research Agenda for CDC Category A Agents in August 2003.

Last Reviewed: August 6, 2019

This document provides information about the NIAID RNCP background, research priorities, funding opportunities, and more.

Last Reviewed: August 6, 2019

This document provides an overview of animal model development and identification, testing, including therapeutics and vaccines for fungal diseases.

Last Reviewed: August 6, 2019

NIAD document version control guidelines for Division of Microbiology and Infectious Diseases (DMID)-sponsored clinical research

Last Reviewed: August 6, 2019

This WORD document provides a tool for evaluating organization review, coordinate and maintain oversight of all applications and proposal

Last Reviewed: August 6, 2019

This document outlines the guidelines for the diagnosis and management of food allergy in the US, specifically for patients, families, and caregivers.

Last Reviewed: July 9, 2019

This document incudes detailed instructions for the general use of the DAIDS protocol specific informed consent template, updated in 2012.

Last Reviewed: August 6, 2019

This document incudes detailed instructions for the general use of the DAIDS protocol specific informed consent template, updated in 2013.

Last Reviewed: August 6, 2019

This document focuses on designing Monte Carlo implementation of hypothesis tests and the common examples of such tests are bootstrap or permutation tests.

Last Reviewed: August 6, 2019

NIAID Form: Verification of equivalence of translated document(s) forr Division of Microbiology and Infectious Diseases (DMID)-funded research.

Last Reviewed: August 6, 2019

This document provides a link to the updated report by NIAID "Current Efforts in Lyme Disease Research" 2019.

Last Reviewed: July 9, 2019

This document incudes detailed instructions for the general use of the DAIDS protocol specific informed consent template, updated in February 2016.

Last Reviewed: August 6, 2019

This document describes the Division of Microbiology and Infectious Disease (DMID) policy on Food and Drug Administration (FDA) inspections of DMID as a sponsor

Last Reviewed: August 6, 2019

This document provides an overview of the 2006 Progress Report regarding the NIAID Biodefense Research Agenda for CDC Category A Agents.

Last Reviewed: August 6, 2019

This document provides a summary of the addendum guidelines for the prevention of peanut allergies in the US provided by the NIAID expert panel.

Last Reviewed: July 9, 2019

This document provides an overview of the murine model of gastrointestinal candidiasis and how it is validated with two separate wild-type isolates of Candida albicans.

Last Reviewed: August 6, 2019

This document summarizes study of Candida albicans Murine Invasive Candidiasis Model and how it been validated with two separate wild-type isolates.

Last Reviewed: August 6, 2019

This document outlines the different characteristics of a clinical endpoint, co-equal primary endpoints, co-equal surrogated endpoints and various ranking methods.

Last Reviewed: August 6, 2019

Generic Preclinical Development Plan for Human Monoclonal Antibodies

Last Reviewed: August 1, 2024

This PowerPoint details information of safety monitoring plans and procedures including assessing, documenting, and reporting adverse event

Last Reviewed: October 18, 2018

This document outlines Testing for Measles, Streptococcus, and Mononucleosis

Last Reviewed: November 8, 2017

This document outlines the use of DNA sequencing and computers to analyze biological data.

Last Reviewed: February 8, 2018

This document outlines Simulation of Testing for Measles, Streptococcus, and Mononucleosis.

Last Reviewed: November 8, 2017